Medial Canthal Block in patients undergoing cataract surgery Cataract, Medial Canthal Block, Ropivacaine, Bupivacaine
Conditions
Interventions
Medial Canthal Block in Cataract Surgery Using Euvolemic Mixtures Ropivacaine 0.375%-Lignocaine 1% ,Medial Canthal Block in Cataract Surgery Using Euvolemic Mixture of Bupivacaine 0.25%-Lignocaine 1
Active Comparator Drug,Active Comparator Drug
Medial Canthal Block in Cataract Surgery ,Medial Canthal Block in Cataract Surgery
Sponsors
Mantish Kumar
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients planned for cataract surgery ASA grades I to III Age 18 years - 70 year
Exclusion criteria
Exclusion criteria: Refusal of consent Infection at the site of injection Abnormal coagulation status Patients allergic to any of the study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular Akinesia At 2,4,6,8 and 10 minutes after intervention Brahma and colleagues Scoring System | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical Satisfaction Score At 10 minutes after intervention Visual Scoring Method | — |
Countries
India
Contacts
Public ContactMantish Kumar
Tata Main Hospital
Outcome results
None listed